ArticleJournal of the National Cancer Institute2026
Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.
W Marston Linehan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.